Friday, November 21, 2014
Print Current Session:
|
|
Friday
SESSION 77:
CAS Vs. CEA RELATED TOPICS: THE FUTURE FOR CAS IS BRIGHT
Moderators:Ross Naylor, MD, FRCS / Frank J. Veith, MD
|
|
SESSION 77 SCHEDULE | |
10:10 AM - 10:15 AM | Despite Various Claims, What Is The Current Truth About The Effects Of CAS And CEA On Cognitive Function: Is There A Difference Between The Procedures |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Abstract | |
10:16 AM - 10:21 AM | Carotid Procedures (CEA Or CAS) For Acute Stroke: When Should They Be Done And How |
Presenter(s):Laura Capoccia, MD, PhD | |
View Abstract | |
10:22 AM - 10:27 AM | Outcome Of A High Risk Plaque Study In 6100 Americans: What Does It Tell Us |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
10:28 AM - 10:33 AM | The Truth About The High Risk Carotid Patient And Which Patients Should Be Enrolled In Future Carotid Trials |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
10:34 AM - 10:39 AM | Long-Term Stroke Risk After CEA Has Been Lower Than After CAS: Based On VQI And Medicare US Population-Wide Data |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
10:40 AM - 10:45 AM | DEBATE: CMS (Medicare) Should Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients |
Presenter(s):William A. Gray, MD | |
View Abstract | |
10:46 AM - 10:51 AM | DEBATE: CMS Should Not Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
10:52 AM - 10:57 AM | Will Recent Improvements In Medical Therapy Lower Stroke Risk In Asymptomatic Carotid Stenosis Patients So Much That Further Treatment Will Be Unnecessary: Are The ACST And ACSRS Studies Now Obsolete And Will They Have To Be Done Again: Is There A High Risk Asymptomatic Patient Group That Will Benefit From CEA Or CAS |
Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD | |
View Abstract | |
10:58 AM - 11:05 AM | Panel Discussion |
THE FUTURE FOR CAS IS BRIGHT | |
Moderator(s): Thomas G. Brott, MD / Wesley S. Moore, MD | |
11:05 AM - 11:10 AM | Why CAS Will Have A Renaissance And What Studies Are Needed To Justify It: The Mesh Covered Scaffold Stent (Gore) Should Help |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
11:11 AM - 11:16 AM | How To Improve CAS And Prevent Post-Procedural Strokes After CAS: Clinical Experience With The Roadsaver Micromesh Carotid Stent: How Does The Micromesh Stent Compare To Other Mesh-Covered Stents Like The MicroNet (C-Guard) Stent From InspireMD And the Scaffold Stent From Gore |
Presenter(s):Max Amor, MD | |
View Abstract | |
11:17 AM - 11:22 AM | A New Development In CAS Which Will Improve Results: Is The Cervical Flow Reversal Device (Michi System) From Silk Road The Safest Way To Perform CAS: When Will We Know How Well It Works |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Abstract | |
11:23 AM - 11:28 AM | What Is The Pathological And Functional Significance Of Diffusion Weighted MRI (DW MRI) Defects After CEA And CAS: Are They Irrelevant Or A Bad Thing |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
INTENSIVE MEDICAL THERAPY WITH PROPER STATIN USAGE ETC. IS A DISRUPTIVE INFLUENCE | |
11:29 AM - 11:34 AM | Intensive Medical Therapy With Proper Statin Usage Etc. Is A Disruptive Influence |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
11:35 AM - 11:40 AM | The CREST Trial Did Not Optimize Medical Treatment And Risk Factor Control Especially In the CEA Treated Patients: What Are The Implications |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
11:41 AM - 11:46 AM | How Will ACST 2, SPACE 2 And CREST 2 Change The CAS vs. CEA Game |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Abstract | |
11:47 AM - 11:52 AM | What Will The ECST-2 Trial Tell Us About CEA, CAS And Medical Treatment: What Is The Significance Of White Matter And Other MRI Lesions |
Presenter(s):Martin M. Brown, MD | |
View Abstract | |
11:53 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 77 | |
previous | next |